Colony Laboratories, Inc.
United StatesFDA applicant, unverified
- Devices
- 16
What Colony Laboratories, Inc. makes
Colony Laboratories, Inc. manufactures calibrator and assay kits for therapeutic drug monitoring, including digoxin, theophylline, phenytoin, phenobarbital, carbamazepine, gentamicin, amikacin, and tobramycin. These products are designed for use in clinical laboratories to measure drug concentrations in patient samples, supporting precision in medication management.
The company’s portfolio is regulated under FDA’s 510(k) pathway, with devices classified as Class I and Class II. Products are listed in the FDA’s 510(k) database, reflecting their compliance with U.S. medical device regulations. The manufacturer operates from the United States.
Catalogue
Search and filter all 16 devicesFrequently asked questions
How many devices does Colony Laboratories, Inc. have in the registry?
The registry currently lists 16 devices for Colony Laboratories, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Colony Laboratories, Inc.'s devices?
Among its 16 most recently registered devices, Colony Laboratories, Inc. has devices listed in FDA 510(k) (16 devices).
What risk classes do Colony Laboratories, Inc.'s devices fall under?
Among its 16 most recently registered devices, the classes recorded for Colony Laboratories, Inc.'s devices are Class I and Class II. Each device page shows its own class and authorisation.
What are the newest devices from Colony Laboratories, Inc. in the registry?
The most recently registered devices listed for Colony Laboratories, Inc. include FPR DIGOXIN CALIBRATOR KIT, FPR GENTAMICIN CALIBRATOR KIT, FPR DIGOXIN KIT and FPR THEOPHYLLINE KIT.